Rethinking Food and Agriculture 2020-2030: The Second Domestication of Plants and Animals, the Disruption of the Cow, and the Collapse of Industrial Livestock Farming
Industrial Biotechnology · 01.04.2021 · 17 (2) · 57-72
DOI: 10.1089/ind.2021.29240.ctu ↗Kurz gefasst
Fachartikel in der Zeitschrift Industrial Biotechnology, erschienen am 01.04.2021. Verfasst von Catherine Tubb und 1 weiteren Autor:innen. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Abstract (Originalsprache)
By 2030, the number of cows in the U.S. will have fallen by 50% and the cattle farming industry will be all but bankrupt. All other livestock industries will suffer a similar fate, while the knock-on effects for crop farmers and businesses throughout the value chain will be severe. Rethinking Food and Agriculture shows how the modern food disruption, made possible by rapid advances in precision biology and an entirely new model of production we call Food-as-Software, will have profound implications not just for the industrial agriculture industry, but for the wider economy, society, and the environment.
Zitieren
APA
Tubb, C., & Seba, T. (2021). Rethinking Food and Agriculture 2020-2030: The Second Domestication of Plants and Animals, the Disruption of the Cow, and the Collapse of Industrial Livestock Farming. Industrial Biotechnology, 17(2), 57-72. https://doi.org/10.1089/ind.2021.29240.ctu
Vancouver
Tubb C, Seba T. Rethinking Food and Agriculture 2020-2030: The Second Domestication of Plants and Animals, the Disruption of the Cow, and the Collapse of Industrial Livestock Farming. Industrial Biotechnology. 2021;17(2):57-72. doi:10.1089/ind.2021.29240.ctu
BibTeX
@article{Tubb2021,
author = {Tubb, Catherine and Seba, Tony},
title = {Rethinking Food and Agriculture 2020-2030: The Second Domestication of Plants and Animals, the Disruption of the Cow, and the Collapse of Industrial Livestock Farming},
journal = {Industrial Biotechnology},
year = {2021},
volume = {17},
number = {2},
pages = {57--72},
doi = {10.1089/ind.2021.29240.ctu}
}
EUVIMED